GlaxoSmithKline has sent three top executives to China to deal with a storm arising from corruption allegations in the pharmaceutocal giant.
Chief Executive Andrew Witty dispatched the company’s President of Emerging Markets Abbas Hussain, along with the group’s Global Head of Internal Audit and a senior legal official.
All three have now arrived in China to cooperate with Chinese authorities, trying to get to the bottom of a scandal that has shaken confidence in GSK’s internal procedures. The drugmaker has also hired auditors Ernst & Young to carry out an independent review of its systems in China, another resource said.
On July 15, Chinese police charged GSK for bribing officials and doctors to boost sales and raise the price of its medicines in China. GSK said it was deeply concerned by the allegations, which it called "shameful".
Dog survives after 30 hours buried in debris
Feedback
RSS
